AlphaYouKA
Insider selling
Keith A. Goldan sold $22K of Syndax Pharmaceuticals Inc (SNDX) stock
Keith A. Goldan, Chief Financial Officer of Syndax Pharmaceuticals Inc (SNDX), sold 1,177 shares of SNDX stock worth $22K, per an SEC Form 4 filed Jun 2, 2026.
It was an open-market sale.
The trade happened on Jun 1, 2026, 1 day before it was made public.
SNDX has moved -4.1% since the trade date, from $18.85 to $18.07 (Sep 21, 2026 close).
- Traded
- Jun 1, 2026
- Disclosed
- Jun 2, 2026
- Filing delay
- 1 day
- Price since
- -4.1%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More SNDX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.